SCHEMBL3783536

SCHEMBL3783536

Nc1ccc(-c2cccc(Oc3ccccc3)c2N)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.67
NCOA3 Q9Y6Q9 1/20 0.67
MAOA P21397 1/20 0.52
ADORA2A P29274 1/20 0.46
PTGS2 P35354 1/20 0.46
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MITF O75030 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
GFER P55789 1/20 0.44
NLRP1 Q9C000 1/20 0.44
NOD2 Q9HC29 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
NLRP3 Q96P20 1/20 0.43
MAOB P27338 1/20 0.43
HRH1 P35367 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25135230 0.93 NCOA1 (0.77) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL3792074 0.91 NCOA1 (0.62) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL23467021 0.90 ALDH1A1 (0.53) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL3786953 0.87 NCOA1 (0.86) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL6681917 0.83 ADORA2A (0.53) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL25135238 0.83 MAOB (0.58) NCOA1NCOA3MAOAADORA2APTGS2
SCHEMBL3786926 0.83 NCOA1 (0.54) NCOA1NCOA3MAOAADORA2AALDH1A1
SCHEMBL23045907 0.83 NCOA1 (0.62) NCOA1NCOA3MAOAADORA2AALDH1A1
SCHEMBL5745005 0.82 NCOA1 (0.89) NCOA1NCOA3MAOAPTGS2ALDH1A1
SCHEMBL4965451 0.81 NCOA1 (0.53) NCOA1NCOA3MAOAADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 NCOA1 2120/4885NCOA3 989/4885MAOA 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.